Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07433647 · ClinicalTrials.gov registry record

Evaluation of Brain MRI Changes in Cerebral Palsy Patients

A clinical trial of Cerebral Palsy and Spastic Diplegia, sponsored by Columbia University.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT07433647: Recruiting study of Cerebral Palsy and Spastic Diplegia, sponsored by Columbia University.

NCT07433647 is a study of Cerebral Palsy and Spastic Diplegia that is actively recruiting participants, run by Columbia University. The registered enrollment target is 30 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07433647, a study of Cerebral Palsy and Spastic Diplegia, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Cerebral palsy (CP) is a neurodevelopmental syndrome characterized by sensorimotor impairment that arises during early childhood defined as a static insult to the developing brain. A key part of the definition for CP is a non-progressive brain injury; however, as individuals with CP age, a functional decline greater than neurotypical individuals is often present. The investigators are doing this research study to improve understanding of whether there is brain and spinal cord atrophy over time that could indicate neurodegeneration. To do this, the investigators will partner with the Cerebral Palsy Research Network to obtain brain and spinal cord MRIs from people with CP across the United States. The investigators will perform analyses on multiple longitudinal MR images of the brain and spinal cord obtained from adults with CP. Putative changes will be related with changes in function across time. ... This will be a single-center study that will compare retrospective clinical and imaging data with similar prospective data. The objective is to find out if people with Cerebral Palsy (CP) experience changes in the structures of their brain over time. A key part of the CP definition is that it is a non-progressive brain injury. However, as people with CP age, their function often deteriorates. This study seeks to determine whether changes in the brain structure may result in function changes, as they do in other types of brain injuries. The investigators are doing this research study to improve understanding of whether there is brain and spinal cord atrophy over time that could indicate neurodegeneration. To do this, the investigators will partner with the Cerebral Palsy Research Network to obtain brain and spinal cord MRIs from people with CP across the United States, as well as locally. The investigators will perform analyses on multiple longitudinal MR images of the brain and spinal cord obtained from adults with CP. Putative changes will be related with changes in

Primary Outcome

This is a number, measured in cubic millimeters, that includes the output from segmentation of each individual MRI scan per subject.

Study Locations (1)

New York

  • Weinberg Family Cerebral Palsy Center, Columbia University - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-06-20
Est. Completion 2029-07-01
Columbia University

958 total trials

What NCT07433647 shows while recruiting

NCT07433647 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower).

The record links to 4 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.

NCT07433647 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07433647 about?

NCT07433647 is a clinical study titled "Evaluation of Brain MRI Changes in Cerebral Palsy Patients". Cerebral palsy (CP) is a neurodevelopmental syndrome characterized by sensorimotor impairment that arises during early childhood defined as a static insult to the developing brain. A key part of the definition for CP is a non-progressive brain injury; however, as individuals with CP age, a functiona...

What is the current status of trial NCT07433647?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-06-20. Estimated completion is 2029-07-01.

What conditions does trial NCT07433647 study?

This clinical trial studies the following conditions: Cerebral Palsy, Spastic Diplegia, Spastic Quadriplegia, Spastic Hemiplegia.

Who is sponsoring clinical trial NCT07433647?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07433647 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07433647's enrollment target sits among peer trials

30 55th of 91 higher than 29 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07433647, the US trial registry maintained by the National Library of Medicine. NCT07433647 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.